The device has passed all validation tests prior to use with Covid-19 patients and electromagnetic compatibility tests, so that it currently has authorization from the Spanish Agency for Medicines and Health Products (AEMPS) of the Ministry of Health from Spain for use in hospitals as a clinical study, allowing its effective use with Covid-19 patients.

The RESPIRA project has been developed under the supervision of the Catalan Institute of Health (ICS) of the Generalitat of Catalonia and with the participation of the Hospital Clínic de Barcelona and the Center for Comparative Medicine and Bioimatge of the Germans Trias and Pujol Research Institute - Can Ruti de Badalona , and also has the collaboration of health workers from the Hospital de Sant Joan de Déu in Barcelona .

Developed together with

With the collaboration and participation of our partners

For more information contact

with us through the mail

  • Blanco Icono LinkedIn
  • Twitter Icono blanco

Follow us at

@Gpainnova

#RESPIRA  #GPAINNOVA

C/Caracas 13-15, Nave 6 · 08030 · BARCELONA, España.

www.gpainnova.com

 

a product of

RESPIRAdevice.com © 2020 

Contact with our